利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

13 条记录 (耗时 0.03 秒)

    CANCER STEM CELL MARKERS AND USES THEREOF
    9.
    发明申请
    CANCER STEM CELL MARKERS AND USES THEREOF 审中-公开
    癌症干细胞标记物及其用途

    公开(公告)号：US20120294859A1

    公开(公告)日：2012-11-22

    申请号：US13574260

    申请日：2011-01-20

    申请人： Steffen Goletz ,  Uwe Karsten

    发明人： Steffen Goletz ,  Uwe Karsten

    IPC分类号： A61K39/395 ,  A61P35/02 ,  C12N5/00 ,  A61P35/00 ,  G01N33/53 ,  G01N33/566

    CPC分类号： G01N33/57469 ,  G01N2333/70596

    摘要： The present invention inter alia pertains to therapeutic methods which are based on the use of an agent specifically binding a tumor-associated carbohydrate antigen for the treatment of cancer stem cells and related diseases. Also provided are diagnostic and prognostic methods using a tumor-associated carbohydrate antigen as marker for cancer stem cells.

    摘要翻译： 本发明尤其涉及基于特异性结合肿瘤相关碳水化合物抗原用于治疗癌症干细胞和相关疾病的试剂的使用的治疗方法。 还提供了使用肿瘤相关碳水化合物抗原作为癌症干细胞的标志物的诊断和预后方法。

    METHOD FOR THE PRODUCTION OF AN IMMUNOSTIMULATING MUCIN (MUC1)
    10.
    发明申请
    METHOD FOR THE PRODUCTION OF AN IMMUNOSTIMULATING MUCIN (MUC1) 有权
    生产免疫球蛋白（MUC1）的方法

    公开(公告)号：US20100273992A1

    公开(公告)日：2010-10-28

    申请号：US12818839

    申请日：2010-06-18

    申请人： Steffen GOLETZ ,  Uwe Karsten

    发明人： Steffen GOLETZ ,  Uwe Karsten

    IPC分类号： C07K14/435

    CPC分类号： C07K14/4727 ,  A61K38/1735 ,  A61K39/0005 ,  A61K45/06 ,  A61K2039/505 ,  C07K16/3092 ,  C07K16/44

    摘要： The present invention relates to a method for producing or identifying a MUC1 molecule which is able to generate an immune response in humans. The invention also relates to a method for producing or identifying a cell, cell lines or cell lysates containing a MUC1 molecule that is able to generate an immune response in humans. The invention further relates to methods for producing medicaments and diagnostic agents. Also disclosed is the use of the MUC1 molecules, cells or cell lysates obtained by means of the methods according to the invention for producing a medicament used for treating or preventing tumours. Further disclosed is a purified MUC1 molecule that can be obtained by means of the methods according to the invention and has an immunostimulating effect on humans. The invention additionally relates to the use of a MUC1 antibody for the production of a medicament used for treating or preventing tumours.

    摘要翻译： 本发明涉及能够在人体中产生免疫应答的产生或鉴定MUC1分子的方法。 本发明还涉及产生或鉴定含有能够在人体中产生免疫应答的MUC1分子的细胞，细胞系或细胞裂解物的方法。 本发明还涉及生产药物和诊断剂的方法。 还公开了通过根据本发明的方法获得的MUC1分子，细胞或细胞裂解物用于产生用于治疗或预防肿瘤的药物的用途。 进一步公开的是可以通过本发明的方法获得并且对人类具有免疫刺激作用的纯化的MUC1分子。 本发明还涉及MUC1抗体用于制备用于治疗或预防肿瘤的药物的用途。